News / Events

Recent News View All News

Adial Pharmaceuticals Announces Positive In Vivo Data for Purnovate’s PNV-5030 as a Potential Treatment for Chronic Pain

September 26, 2022

Adial Pharmaceuticals Announces Positive In-Vivo Non-clinical Data with Purnovate’s PNV-6005 as a Potential Treatment for Ulcerative Colitis

September 6, 2022

Upcoming Events View IR Calendar

2022 Annual Meeting of Stockholders

October 13, 2022 • 9:00am EDT

View IR Calendar

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings